Point72 Asia (Singapore)’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-31,514
Closed -$113K 941
2025
Q1
$113K Sell
31,514
-156,489
-83% -$628K 0.03% 388
2024
Q4
$592K Buy
+188,003
New +$672K 0.16% 125
2024
Q2
Sell
-172,158
Closed -$137K 1106
2024
Q1
$137K Buy
172,158
+154,650
+883% +$141K 0.04% 556
2023
Q4
$16.7K Buy
+17,508
New +$17.2K ﹤0.01% 472

Other funds holding CLOV

Point72 Asia (Singapore)'s CLOV Position: Q2 2025 in Review

Point72 Asia (Singapore) sold out of Clover Health Investments (CLOV) in Q2 2025, closing a stake of 31,514 shares — an estimated $113K sold.

Point72 Asia (Singapore) first reported a position in CLOV in Q4 2023 and held it in 4 quarters. The position peaked at $592K in Q4 2024. 200 funds tracked by Wall St. Rank hold CLOV as of Q2 2025.

  • Point72 Asia (Singapore) reported no remaining Clover Health Investments position as of Q2 2025 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 31,514 Clover Health Investments shares in Q2 2025, an estimated $113K.
  • Point72 Asia (Singapore) first reported a position in Clover Health Investments in Q4 2023 and held it in 4 quarters.
  • Point72 Asia (Singapore)'s Clover Health Investments position peaked at $592K in Q4 2024.
  • 200 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q2 2025, filed 14 Aug 2025.